Equillium to Participate in the 2026 Jefferies Global Healthcare Conference

Equillium (Nasdaq: EQ) announced that its management will participate in a fireside chat at the 2026 Jefferies Global Healthcare Conference on Wednesday, June 3, 2026 at 4:55 p.m. EDT.

Rhea-AI Summary

Equillium (Nasdaq: EQ) announced that its management will participate in a fireside chat at the 2026 Jefferies Global Healthcare Conference on Wednesday, June 3, 2026 at 4:55 p.m. EDT. Registered conference investors will also have the opportunity to meet with Equillium’s management team.

Argus May 29 session

+2.11% close to close Open Argus

Details

News Market Reaction – EQ

On May 29, the first trading day after this news, EQ closed 2.11% above the previous close.

Data tracked by StockTitan Argus for the May 29 session.

Market Context

This announcement adds another investor-relations touchpoint as Equillium prepares for a fireside ch...

Analysis

This announcement adds another investor-relations touchpoint as Equillium prepares for a fireside chat at the Jefferies Global Healthcare Conference on June 3, 2026 at 4:55 pm EDT. It follows recent scientific, financial, and corporate updates and coincides with an effective S-3 registering 18,878,101 resale shares and multiple beneficial-ownership filings. Investors may watch for messaging around EQ504, capital structure, and any additional corporate developments discussed at the event.

Key Figures

Conference date: June 3, 2026 Session time: 4:55 pm EDT

Conference date

June 3, 2026

Jefferies Global Healthcare Conference fireside chat

Session time

4:55 pm EDT

Scheduled time for Equillium fireside chat

Historical Context

5 past events · Latest: May 20

5 events

1. May 20

   Investor webinar update

   24h Move

   +7.3%

   Announced investor webinar sharing new preclinical AhR and miR-124 data.

2. May 13

   Earnings and pipeline

   24h Move

   +12.1%

   Reported Q1 2026 results, EQ504 plans, private placement and cash runway.

3. May 1

   Inducement grants

   24h Move

   +1.0%

   Granted stock options to new employees under inducement plan.

4. Apr 20

   Investor conference

   24h Move

   +7.0%

   Announced participation in Oppenheimer’s 2026 Innovation on the Island event.

5. Apr 8

   Scientific posters

   24h Move

   -6.3%

   Announced preclinical EQ504 poster presentations at IMMUNOLOGY2026™.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

LA JOLLA, Calif., May 28, 2026 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders, today announced that management will participate in a fireside chat at the 2026 Jefferies Global Healthcare Conference on Wednesday, June 3, 2026 at 4:55pm EDT.

Members of the Equillium management team will be available to meet with investors who are registered to attend the conference.

About Equillium
Equillium is a biotechnology innovator with a mission to develop highly impactful therapies to treat severe autoimmune and inflammatory disorders.

For more information, visit www.equilliumbio.com.

Investor Contact 
PJ Kelleher
LifeSci Advisors, LLC
+1-617-430-7579
pkelleher@lifesciadvisors.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Equillium (EQ) present at the 2026 Jefferies Global Healthcare Conference?

Equillium will participate in a fireside chat on Wednesday, June 3, 2026, at 4:55 p.m. EDT. According to Equillium, this session is part of the 2026 Jefferies Global Healthcare Conference agenda for institutional investors.

What is Equillium’s focus as it attends the 2026 Jefferies Global Healthcare Conference?

Equillium focuses on developing novel therapies for severe autoimmune and inflammatory disorders. According to Equillium, management’s participation at the Jefferies Global Healthcare Conference supports engagement with investors interested in its biotechnology pipeline and corporate strategy.

Can investors meet Equillium (EQ) management at the 2026 Jefferies Global Healthcare Conference?

Yes, registered investors can meet Equillium’s management team during the conference. According to Equillium, management will be available for meetings with investors who are formally registered to attend the 2026 Jefferies Global Healthcare Conference.

Where is Equillium (EQ) headquartered as it joins the 2026 Jefferies Healthcare Conference?

Equillium is headquartered in La Jolla, California, in the United States. According to Equillium, its leadership team from La Jolla will participate in the 2026 Jefferies Global Healthcare Conference fireside chat and investor meetings.

What type of session will Equillium (EQ) hold at the 2026 Jefferies Global Healthcare Conference?

Equillium will take part in a fireside chat session at the conference. According to Equillium, this conversational format allows management to discuss its autoimmune and inflammatory disorder therapies with institutional investors attending the Jefferies Global Healthcare Conference.